White Sage › Blog › GLP-1 & Weight Loss
GLP-1 & WEIGHT LOSS
Semaglutide vs. Tirzepatide: How to Know Which GLP-1 Is Right for You
There's no single "winner" that's right for everyone. A clear look at what actually separates these two medications, so the conversation with your provider feels clear instead of overwhelming.
If you've decided to explore a GLP-1 medication, you'll quickly run into a fork in the road: semaglutide or tirzepatide? You may know them better by their brand names: Ozempic and Wegovy on one side, Mounjaro and Zepbound on the other. It's one of the most common questions we hear, and it's a good one.
Here's the honest short answer up front: there's no single "winner" that's right for everyone. Both are excellent, well-studied medications. The better question isn't "which is best?" but "which is best for me?" Let's walk through what actually separates them, so that conversation with your provider feels clear instead of overwhelming.
What they have in common
Before the differences, it's worth appreciating how much these two share. Both are part of the GLP-1 family of medications. Both are taken as a simple once-weekly injection at home. Both work by easing appetite, reducing cravings, slowing how quickly your stomach empties, and steadying blood sugar. Both have produced significant, well-documented weight loss in large clinical trials. And both carry a similar set of mostly digestive side effects, along with the same key safety considerations.
In other words, you're not choosing between a good option and a bad one. You're choosing between two strong tools with slightly different profiles.
The key difference: one pathway, or two
The core distinction is beautifully simple. Semaglutide mimics one of your body's natural appetite hormones: GLP-1. Tirzepatide mimics two: GLP-1 and a second, related hormone called GIP.
A helpful way to picture it: if semaglutide turns down the volume on hunger through one channel, tirzepatide turns it down through two. That dual action is why tirzepatide often produces a somewhat stronger effect on appetite and weight for many people. It's the newer of the two medications, and that second pathway is the main reason it tends to come up in conversations about "more substantial" results.
What the head-to-head research shows
For a long time, comparisons between the two relied on separate studies. That changed recently. In a direct head-to-head trial published in 2025, the two medications were compared in the same study over 72 weeks.
On average, participants taking tirzepatide lost about 20% of their body weight, compared with about 14% for those taking semaglutide. Tirzepatide also led to a greater average reduction in waist circumference. Both medications were well tolerated overall, with digestive symptoms being the most common side effect for each.
It's tempting to stop there and declare a winner, but averages deserve a careful read. These are group results. Plenty of individuals do beautifully on semaglutide, and the "best" medication is the one that fits your body, your tolerance, and your circumstances, not simply the one with the higher average in a study. A larger effect also isn't always the goal; the right pace of weight loss is the one that's safe and sustainable for you.
In my clinical practice, I have seen patients succeed with both medications. Some do exceptionally well on semaglutide and have no reason to switch, while others experience side effects that make a different option worth considering. I have also seen patients respond better to tirzepatide, especially when appetite control is the major challenge. The right choice depends less on internet comparisons and more on the individual sitting in front of me.
Side effects and how they're managed
For both medications, the most common side effects are digestive, nausea most of all, sometimes along with other stomach symptoms, particularly in the early weeks or when the dose increases. In the head-to-head trial, slightly fewer people stopped tirzepatide because of these effects than stopped semaglutide, but the difference was modest and both were generally well tolerated.
Far more important than which medication you choose is how it's prescribed. Side effects are strongly tied to how quickly the dose is raised. Starting low, going slow, and adjusting based on how you actually feel is what keeps the experience comfortable, and it's something that simply can't be done well by an automated online service that ships the same schedule to everyone.
Cost, access, and brand names
Practical factors matter too. Insurance coverage, current availability, and out-of-pocket cost can differ between the medications and change over time, and they sometimes end up being the deciding factor regardless of the clinical picture. Your provider can help you weigh these honestly alongside everything else, so the plan is realistic for your life and not just on paper.
At a glance
| Semaglutide | Tirzepatide | |
|---|---|---|
| How it works | Mimics one hormone (GLP-1) | Mimics two hormones (GIP + GLP-1) |
| Brand names | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| How it's taken | Weekly injection (oral form exists) | Weekly injection |
| Avg. weight loss* | ~13.7% at 72 weeks | ~20.2% at 72 weeks |
| Tolerability | GI effects common; slightly higher discontinuation | GI effects common; slightly lower discontinuation |
| Best thought of as | A well-established, strong starting point | A dual-action option for greater effect |
Table footnote: *Average results from a 2025 head-to-head trial over 72 weeks; individual results vary.
So, which one is right for you?
Here's how that decision actually gets made in good clinical care. Your provider considers your medical history and any conditions that make one option more suitable, your goals and how much change you're aiming for, your past experience with appetite and any medications, your tolerance for side effects, and the practical realities of cost and access. Only with that full picture does a recommendation make sense.
That's the real takeaway: the choice between semaglutide and tirzepatide isn't a coin flip or a popularity contest. It's a clinical decision that should be made with you, based on you. The medication is only one part of the plan, and choosing it thoughtfully is the first step in a process that also includes nutrition, muscle preservation, and long-term support.
What the first few months tend to look like
Whichever medication you and your provider choose, the early experience tends to follow a similar arc, and knowing what to expect takes a lot of the anxiety out of starting. You'll almost always begin at a low introductory dose. This isn't the dose that drives most of your results; it's there to let your body adjust gently and to keep side effects to a minimum. Over the following weeks and months, the dose is increased in steps, guided by how you're feeling and how you're responding.
Most people notice the appetite change before they notice the scale change. Within the first week or two, food often feels less interesting and meals feel satisfying sooner. Weight change is usually more gradual, unfolding steadily over months rather than all at once. Plateaus are normal and expected. They're often a cue for a thoughtful adjustment, not a sign that anything is wrong. This is precisely where ongoing check-ins earn their keep: a provider can fine-tune your dose, help you manage any digestive symptoms, and keep the plan moving in the right direction.
Frequently asked questions
Is tirzepatide better than semaglutide?
On average, tirzepatide produced greater weight loss in a head-to-head trial. But "better on average" isn't the same as "better for you." Many people do extremely well on semaglutide, and the right choice depends on your health, tolerance, goals, and access, which is what a consultation sorts out.
Can I switch from one to the other?
In many cases, yes. Switching is sometimes appropriate based on response, tolerability, or access. It should always be done under provider guidance, with the dose managed carefully during the transition.
Do they have different side effects?
The side-effect profiles are similar, and mostly digestive for both. How quickly the dose is increased tends to matter more for comfort than which medication you're on.
Will either one work without changing how I eat?
Both reduce appetite, but lasting results come from pairing the medication with adequate protein, muscle preservation, and sustainable habits. The medication opens the door; what you do alongside it is what makes the change hold.References
Not sure which is right for you? You don't have to decide alone.
At White Sage Metabolic Studio in Bountiful, choosing the right medication is part of a full evaluation built around your physiology and goals, with ongoing support to keep it working safely.
BOOK A CONSULTATIONPrefer to talk first? Call (801) 383-0105
